PRTA FY 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$135M+47.9% YoY

Gross Profit

$135M100.0% margin

Operating Income

-$155M-114.4% margin

Net Income

-$122M-90.5% margin

EPS (Diluted)

$-2.27

Cash Flow

Operating Cash Flow

-$150M

Free Cash Flow

-$150M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$547M

Total Liabilities

$60M

Stockholders' Equity

$487M

Cash & Equivalents

$471M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$135M	$91M	+47.9%
Gross Profit	$135M	$91M	+47.9%
Operating Income	-$155M	-$191M	+19.1%
Net Income	-$122M	-$147M	+16.8%